Market Overview:
The global digestive distress treatment market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of digestive disorders, rising awareness about available treatments, and growing demand for novel therapies. The global digestive distress treatment market is segmented by type into upper GI tract and lower GI tract. The upper GI tract segment is further sub-segmented into gastritis, GERD, peptic ulcer disease (PUD), and esophageal cancer. The lower GI tract segment is further sub-segmented into Crohn’s disease, ulcerative colitis, irritable bowel syndrome (IBS), constipation, and diarrhea. By application, the market is divided into hospital pharmacies, online pharmacies, drug stores,,and specialty clinics. Geographically,,the market has been analyzed across North America,,Latin America,,Europe,,,,Asia Pacific,,,,and Middle East & Africa . Some of the key players operating in this market are AstraZeneca plc., GlaxoSmithKline plc., Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co., Inc.
Product Definition:
Digestive Distress Treatment is a therapy that helps to improve the digestive system. It can help to relieve symptoms such as gas, bloating, constipation, and diarrhea.
Upper GI Tract:
Upper GI tract, also known as the upper gastrointestinal tract, includes the area from the stomach to above the diaphragm. The major function of this part of digestive system is to break down food into nutrients and absorb essential vitamins and minerals. This makes it an important factor in treating digestive distress treatment market.
Lower GI Tract:
The lower GI tract is also known as the bowel, alimentary canal or gastrointestinal tract. The lower GI tract consists of digestive organs such as liver and small intestine. The function of the lower GI tract is to absorb nutrients from food and deliver them to the blood for distribution throughout the body.
According to a survey conducted by American Hospital Formulary, in 2016; around 25 million Americans were suffering from Inflammatory Bowel Disease (IBD).
Application Insights:
The hospital pharmacies segment dominated the global market in 2017. This is owing to factors such as presence of a large patient base with digestive disorders and rising prevalence of chronic conditions, which require regular medication. Furthermore, increasing number of hospitals and pharmacy chains in developing countries including India, China and Brazil is expected to boost product demand over the forecast period.
The online pharmacies accounted for a significant share in 2017 due to growing internet usage population globally for healthcare purposes coupled with technological advancements that have made it easier than ever before for patients to access medical information online. Moreover, companies are entering into partnerships with e-commerce players that offer customers access directly from their homes via mobile devices or computers without having to travel or leave their houses. Such initiatives are expected to increase product penetration across households globally thereby driving demand over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of key players, high awareness levels regarding digestive disorders and easy availability of medicines for treatment. Moreover, increasing prevalence of lifestyle-associated diseases such as diabetes is expected to drive regional growth over the forecast period.
Asia Pacific is expected to witness lucrative growth during the forecast period owing to rising healthcare expenditure by governments and private sectors in countries like China, India and Japan coupled with growing penetration of international brands in this region.
Growth Factors:
- Rising prevalence of digestive disorders: The global prevalence of digestive disorders is increasing rapidly due to the changing lifestyle and dietary habits. This is driving the demand for effective and safe treatment options, which is expected to boost the growth of the digestive distress treatment market.
- Growing awareness about available treatments: There is a growing awareness among people about various types of digestive distress treatments available in the market. This is helping to drive the demand for these treatments, thereby propelling the growth of this market.
- Technological advancements in diagnostic and therapeutic procedures: The technological advancements in diagnostic and therapeutic procedures are aiding in early diagnosis and better management of gastrointestinal diseases, thus boosting demand for digestive distress treatments globally.
Scope Of The Report
Report Attributes
Report Details
Report Title
Digestive Distress Treatment Market Research Report
By Type
Upper GI Tract, Lower GI Tract
By Application
Hospital Pharmacies, Online Pharmacies, Drug Stores, Specialty Clinics
By Companies
Mylan, Takeda Pharmaceuticals, Elan Pharmaceuticals, Novartis, Eli Lilly
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
224
Number of Tables & Figures
157
Customization Available
Yes, the report can be customized as per your need.
Global Digestive Distress Treatment Market Report Segments:
The global Digestive Distress Treatment market is segmented on the basis of:
Types
Upper GI Tract, Lower GI Tract
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Online Pharmacies, Drug Stores, Specialty Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Mylan
- Takeda Pharmaceuticals
- Elan Pharmaceuticals
- Novartis
- Eli Lilly
Highlights of The Digestive Distress Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Upper GI Tract
- Lower GI Tract
- By Application:
- Hospital Pharmacies
- Online Pharmacies
- Drug Stores
- Specialty Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Digestive Distress Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Digestive distress treatment is a type of medical care that is used to help relieve symptoms of digestive problems. Treatment may include medications, dietary changes, or both.
Some of the major companies in the digestive distress treatment market are Mylan, Takeda Pharmaceuticals, Elan Pharmaceuticals, Novartis, Eli Lilly.
The digestive distress treatment market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Digestive Distress Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Digestive Distress Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Digestive Distress Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Digestive Distress Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Digestive Distress Treatment Market Size & Forecast, 2018-2028
4.5.1 Digestive Distress Treatment Market Size and Y-o-Y Growth
4.5.2 Digestive Distress Treatment Market Absolute $ Opportunity
Chapter 5 Global Digestive Distress Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Digestive Distress Treatment Market Size Forecast by Type
5.2.1 Upper GI Tract
5.2.2 Lower GI Tract
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Digestive Distress Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Digestive Distress Treatment Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Online Pharmacies
6.2.3 Drug Stores
6.2.4 Specialty Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Digestive Distress Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Digestive Distress Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Digestive Distress Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Digestive Distress Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Digestive Distress Treatment Market Size Forecast by Type
9.6.1 Upper GI Tract
9.6.2 Lower GI Tract
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Digestive Distress Treatment Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Online Pharmacies
9.10.3 Drug Stores
9.10.4 Specialty Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Digestive Distress Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Digestive Distress Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Digestive Distress Treatment Market Size Forecast by Type
10.6.1 Upper GI Tract
10.6.2 Lower GI Tract
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Digestive Distress Treatment Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Online Pharmacies
10.10.3 Drug Stores
10.10.4 Specialty Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Digestive Distress Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Digestive Distress Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Digestive Distress Treatment Market Size Forecast by Type
11.6.1 Upper GI Tract
11.6.2 Lower GI Tract
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Digestive Distress Treatment Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Online Pharmacies
11.10.3 Drug Stores
11.10.4 Specialty Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Digestive Distress Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Digestive Distress Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Digestive Distress Treatment Market Size Forecast by Type
12.6.1 Upper GI Tract
12.6.2 Lower GI Tract
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Digestive Distress Treatment Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Online Pharmacies
12.10.3 Drug Stores
12.10.4 Specialty Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Digestive Distress Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Digestive Distress Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Digestive Distress Treatment Market Size Forecast by Type
13.6.1 Upper GI Tract
13.6.2 Lower GI Tract
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Digestive Distress Treatment Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Online Pharmacies
13.10.3 Drug Stores
13.10.4 Specialty Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Digestive Distress Treatment Market: Competitive Dashboard
14.2 Global Digestive Distress Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Mylan
14.3.2 Takeda Pharmaceuticals
14.3.3 Elan Pharmaceuticals
14.3.4 Novartis
14.3.5 Eli Lilly
